AS Grindeks
GRD1R · Nasdaq Riga · Health Care · Pharmaceuticals
About the company
Grindeks is Latvia's largest pharmaceutical manufacturer and one of the leading pharmaceutical companies in the Baltic States. The company develops, produces, and distributes generic medicines and active pharmaceutical ingredients, exporting to over 90 countries. It is best known internationally for developing mildronate, a cardioprotective drug widely used in Eastern Europe and Central Asia.
| Exchange | Nasdaq Riga |
| Ticker | GRD1R |
| Sector | Health Care · Pharmaceuticals |
| Indicative market cap USD | $90.00M |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (Nasdaq Riga), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Nasdaq Riga, the regulated stock exchange of Latvia operated by Nasdaq, Inc. and part of the Nasdaq Baltic integrated market platform covering Estonia, Latvia, and Lithuania. — official exchange listing
Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Latvia
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker.